Pancreatic Cancer Research

ResearcherHarbin Medical UniversityActive in the last 2 years

Xingming Jiang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0009-4275-0129; OpenAlex author ID A5103285271. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: 1 paper

Papers 3

  1. Ferroptosis: New Strategies and Ideas for the Treatment of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.31083/j.fbl2901045↗
  2. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis. Last author DOI 10.1016/j.prp.2020.153074↗
  3. Tectonic 1 Is a Key Regulator of Cell Proliferation in Pancreatic Cancer. Co-author DOI 10.1089/cbr.2014.1778↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chengru Yang · 1 shared paper, 2024 · strength 0.22
  2. Haolin Bao · 1 shared paper, 2024 · strength 0.22
  3. Xiangyu Zhong · 1 shared paper, 2024 · strength 0.22
  4. Weina Wang · 1 shared paper, 2020 · strength 0.13
  5. Pengcheng Kang · 1 shared paper, 2016 · strength 0.07
  6. Shiyong Zhao · 1 shared paper, 2016 · strength 0.07
  7. Yunfu Cui · 1 shared paper, 2016 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.